Insulet's GAAP loss for six months of 2021 was $25 million, compared to a profit of $12.3 million in the previous year. Revenue increased 21.5% to $515.5 mln, compared to $424.3 mln a year earlier.
Insulet's GAAP loss for six months of 2021 was $25 million, compared to a profit of $12.3 million in the previous year. Revenue increased 21.5% to $515.5 mln, compared to $424.3 mln a year earlier. 
investor.insulet.com
English (US) 